IEQ Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Sell |
34,048
-19,180
| -36% | -$97.1K | ﹤0.01% | 1641 |
|
|
2025
Q1 | $282K | Buy |
53,228
+19,180
| +56% | +$101K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $230K | Hold |
34,048
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q3 | $224K | Hold |
34,048
| – | – | ﹤0.01% | 1027 |
|
|
2024
Q2 | $255K | Hold |
34,048
| – | – | ﹤0.01% | 847 |
|
|
2024
Q1 | $339K | Hold |
34,048
| – | – | ﹤0.01% | 739 |
|
|
2023
Q4 | $336K | Buy |
34,048
+7,168
| +27% | +$70.7K | 0.01% | 701 |
|
|
2023
Q3 | $206K | Buy |
26,880
+8,960
| +50% | +$68.5K | ﹤0.01% | 832 |
|
|
2023
Q2 | $134K | Hold |
17,920
| – | – | ﹤0.01% | 834 |
|
|
2023
Q1 | $120K | Hold |
17,920
| – | – | ﹤0.01% | 845 |
|
|
2022
Q4 | $138K | Hold |
17,920
| – | – | ﹤0.01% | 756 |
|
|
2022
Q3 | $191K | Buy |
+17,920
| New | +$191K | 0.01% | 775 |
|